Otitis externa other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 11: | Line 11: | ||
*Additionally, [[Gallium Citrate Ga 67]] scans will reveal extent of the spread of malignant otitis externa infection. | *Additionally, [[Gallium Citrate Ga 67]] scans will reveal extent of the spread of malignant otitis externa infection. | ||
**The [[gallium citrate]] is absorbed by the macrophages and reticular endothelial cells in the areas of the [[temporal]] or intracranial bones that display markers for [[inflammation]]. | **The [[gallium citrate]] is absorbed by the macrophages and reticular endothelial cells in the areas of the [[temporal]] or intracranial bones that display markers for [[inflammation]]. | ||
*[[Gallium Citrate Ga 67]] is preferred to [[Technetium-99m]] for scintigraphic scans due to the tendency of Tc-99m to be overly sensitive to osteoblast activity, often resulting in positive malignant otitis externa results prematurely, as well as displaying lingering positive results after the infection is treated. | *[[Gallium Citrate Ga 67]] is preferred to [[Technetium-99m]] for scintigraphic scans due to the tendency of Tc-99m to be overly sensitive to osteoblast activity, often resulting in positive malignant otitis externa results prematurely, as well as displaying lingering positive results after the infection is treated. | ||
**[[Ga 67]] scans will provide more accurate findings regarding ongoing malignant otitis externa infection. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:45, 25 May 2016
|
Otitis externa Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Otitis externa other imaging findings On the Web |
|
American Roentgen Ray Society Images of Otitis externa other imaging findings |
|
Risk calculators and risk factors for Otitis externa other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
Other imaging findings
Nuclear Scintigraphy
- For malignant otitis externa, Technetium-99m-based scintigraphy will reveal the extent of the infectious damage on the temporal and intracranial bones.[1]
- Tc-99m analysis will display findings of activity of osteoblast cells that are indicative of infection from malignant otitis externa.[2]
- Additionally, Gallium Citrate Ga 67 scans will reveal extent of the spread of malignant otitis externa infection.
- The gallium citrate is absorbed by the macrophages and reticular endothelial cells in the areas of the temporal or intracranial bones that display markers for inflammation.
- Gallium Citrate Ga 67 is preferred to Technetium-99m for scintigraphic scans due to the tendency of Tc-99m to be overly sensitive to osteoblast activity, often resulting in positive malignant otitis externa results prematurely, as well as displaying lingering positive results after the infection is treated.
- Ga 67 scans will provide more accurate findings regarding ongoing malignant otitis externa infection.
References
- ↑ Leahy TW, Sader C (2011). "A rare case of bilateral malignant otitis externa and osteomyelitis with lower cranial nerve sequelae". BMJ Case Rep. 2011. doi:10.1136/bcr.03.2011.3957. PMC 3094778. PMID 22696730.
- ↑ Chen JC, Yeh CF, Shiao AS, Tu TY (2014). "Temporal bone osteomyelitis: the relationship with malignant otitis externa, the diagnostic dilemma, and changing trends". ScientificWorldJournal. 2014: 591714. doi:10.1155/2014/591714. PMC 4052568. PMID 24963511.